Page last updated: 2024-09-03

16-hydroxycleroda-3,13(14)-dien-15,16-olide and Kidney Neoplasms

16-hydroxycleroda-3,13(14)-dien-15,16-olide has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YC; Chia, YC; Huang, BM; Lee, WC; Liu, C1

Other Studies

1 other study(ies) available for 16-hydroxycleroda-3,13(14)-dien-15,16-olide and Kidney Neoplasms

ArticleYear
16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Dec-01, Volume: 36

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Diterpenes; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases

2017